Condition
Venous Thromboembolism clinical trials and research
As of November 12, 2026, Find a Trial lists 50 Venous Thromboembolism clinical trials that are recruiting, at sites in 41 countries (most in United States (14), France (12), Canada (9)). By phase: Phase 3 (8), Phase 4 (8), Phase 2 (3), Phase 2/3 (1). The most active sponsors are Ottawa Hospital Research Institute (6), University Hospital, Brest (3), University Hospital, Angers (2). There are also 23 NIH-funded research projects on Venous Thromboembolism, with $17.8 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 50Clinical trials
- 23NIH research projects
- 41Countries
Newest Venous Thromboembolism clinical trials
All recruiting trials (50)
-
DoACs vs LMWH for blood flow after knee replacement
This study tests whether rivaroxaban, apixaban, or LMWH work differently to support blood flow in the legs after total knee replacement in adults.
-
Prognostic value of the 2026 AHA/ACC PE classification in ED patients with acute PE
This study tests whether the 2026 AHA/ACC five-category PE classification helps predict 30-day major adverse pulmonary embolism events in adults with acute PE presenting to the ED.
-
Screening for blood clots in adults with acute heart failure
This trial tests whether a guideline-based screening approach can detect pulmonary embolism in adults admitted with acute heart failure.
-
Blood test and software to guide treatment for venous thromboembolism
This project tests whether a blood-based ctDNA test combined with a software risk score can predict if VTE will come back in adults with cancer-associated DVT or PE who have finished 3–12 months of anticoagulation.
-
Aspiration thrombectomy with the Symphony or Prodigy devices
This project will try the Symphony and Prodigy aspiration thrombectomy devices to remove arterial, venous, or pulmonary blood clots in adults.
-
Combining European cohort data to find biomarkers that guide treatment for venous thromboembolism
This project combines clinical, biological and imaging data from European patient cohorts to try to find biomarkers that predict clot recurrence, bleeding, or death in people with venous thromboembolism.
-
Rosuvastatin to help prevent blood clots in cancer patients
This study tests whether taking rosuvastatin daily for a year can lower the chance of dangerous blood clots in people with newly diagnosed or relapsed cancer who aren’t planned to receive blood-thinning medicine.
-
Predicting Blood Clots in Cancer Patients on Chemotherapy
This study tests whether blood biomarkers measured during chemotherapy can predict which cancer patients will develop a venous thromboembolism (VTE).
-
Apixaban versus enoxaparin to prevent blood clots after head and neck cancer surgery
This compares apixaban pills to daily enoxaparin shots to see if the pill is a safe and easier way to prevent blood clots after head and neck cancer surgery.
-
Comparing SRSD107 and enoxaparin to prevent clots after total knee replacement
It will test whether three dose levels of an experimental drug, SRSD107, work as well and are as safe as daily enoxaparin for preventing blood clots in adults aged 60–80 having elective primary unilateral total knee replacement.
-
Comparing Pulsed Electromagnetic Field Therapy and Pneumatic Compression for Preventing Blood Clots in ICU Patients
This study is testing whether Pulsed Electromagnetic Field Therapy works better than pneumatic compression to prevent blood clots in ICU patients who can't take medication for it.
-
Predicting thrombosis risk in lung cancer patients on immune therapy
This study is trying to see if certain factors can help predict the risk of blood clots in lung cancer patients receiving immune therapy.
-
Kinisoquin to prevent blood clots in people with advanced pancreatic cancer
This trial will test whether Kinisoquin can prevent blood clots in people starting chemotherapy for metastatic or locally advanced pancreatic cancer.
-
Timing of anticoagulation for preventing blood clots in patients with brain hemorrhage
This study is testing whether starting blood-thinning treatment early or later can help prevent blood clots in patients with bleeding in the brain while keeping them safe from more bleeding.
-
Improving decision-making for managing unprovoked venous thromboembolism
This study is testing a new way to help patients with unprovoked blood clots decide how long to take blood thinners, to see if it leads to better health outcomes.
-
Evaluating complications of anticoagulant treatment in cancer patients with blood clots
This study looks at how often blood clots and bleeding problems happen in cancer patients who are being treated with blood thinners.
-
Managing blood clot prevention in cancer patients with catheter-related DVT
This study is testing whether giving a low dose of a blood thinner to cancer patients with a history of blood clots can help prevent new clots from forming.
-
Personalized blood thinner treatment for hip and knee replacement patients
This study is testing if personalized blood thinner treatments can better prevent blood clots and bleeding in patients getting hip or knee replacements compared to standard treatments.
-
Comparing apixaban to no anticoagulant in surgery patients
This study is testing if taking the blood thinner apixaban for 28 days after abdominal or pelvic surgery can help prevent blood clots in patients who are at risk.
-
Postpartum aspirin to prevent blood clots after delivery
A 3rd-phase trial tests whether taking a small daily dose of aspirin for 6 weeks after giving birth works as well as usual preventive injections of LMWH to reduce blood clots in people with pregnancy-related clotting risk.
-
Evaluating a new decision support tool for diagnosing blood clots
This study is testing a new tool to help doctors diagnose blood clots in patients who might have conditions like pulmonary embolism or deep vein thrombosis, using fresh blood samples.
-
Colchicine to reduce inflammation after proximal deep vein thrombosis
This trial will try daily low‑dose colchicine (0.5 mg) versus a matching placebo in adults with a first proximal lower‑leg DVT to see if it lowers the chance of developing post‑thrombotic syndrome.
-
Effects of a Walking Test on Blood Clotting in Patients
This study tests how a 60-minute walking test affects blood clotting in people with and without a history of blood clots.
-
Lowering stomach and intestinal bleeding with omeprazole in older adults with a new blood clot
This pilot will test whether taking omeprazole reduces stomach or intestinal bleeding in people 65 and older who are starting blood thinners for a new venous blood clot.
-
Smart technology for patient-centered care in pulmonary embolism
A smartphone-based program using wearable tech and AI will help people with pulmonary embolism manage their health and see if it improves long-term outcomes.
-
Using advanced imaging to predict the risk of blood clot recurrence in pulmonary embolism patients
This study is testing if advanced imaging can help find out which patients with a history of pulmonary embolism are at risk for blood clots coming back, so they can get the right treatment.
-
Comparing rivaroxaban and low-molecular weight heparin for preventing blood clots in patients with lower limb trauma
This study is testing if a new blood thinner called rivaroxaban can prevent blood clots better than a standard treatment in patients with leg injuries who are at high risk for clots.
-
Evaluating the use of compression stockings for patients needing blood-thinning medication after surgery
This study is testing if wearing compression stockings can help high-risk surgical patients who are on blood-thinning medication avoid dangerous blood clots.
-
Preventing blood clots in cancer patients receiving treatment
This study is testing if the blood thinner rivaroxaban can help prevent blood clots in cancer patients with genitourinary cancers who are starting treatment.
-
Using supplemental oxygen to treat pulmonary embolism
This study is testing if giving extra oxygen to people with acute pulmonary embolism can help their heart function better and improve their overall health.
-
Study on the safety and performance of Celect Platinum Vena Cava Filters
This study is testing how safe and effective the Celect Platinum Vena Cava Filters are for patients over time after they've had them placed in their bodies.
-
Evaluating anticoagulation management during pregnancy and postpartum
This study is trying to see how well anticoagulation management works for pregnant people using a specific medication to help prevent blood clots during and after pregnancy.
-
Preventing blood clots in patients undergoing varicose vein treatment
This study tests different blood-thinning medications to see which one best helps prevent blood clots in adults getting treatment for varicose veins.
-
Comparison of ClotTriever System and Anticoagulation for Deep Vein Thrombosis
This study is testing if the ClotTriever System can help people with painful deep vein blood clots feel better compared to the usual blood-thinning medications.
-
Preventing blood clots in outpatients with newly diagnosed grade 4 glioma using apixaban
This trial will test whether taking apixaban can prevent dangerous blood clots in adults newly diagnosed with grade 4 glioma.
-
Using geko device to prevent blood clots in stroke patients
This study is testing if the geko™ device can help prevent blood clots in stroke patients who can’t move around, compared to the standard treatment they usually get.
-
Registry for the use of NOACs in patients with Atrial Fibrillation or Venous Thromboembolism
This study is looking to see how well new blood thinners called NOACs work for people with Atrial Fibrillation or blood clots, by tracking their treatment and outcomes over time.
-
Evaluating DOAC levels in Chinese patients with atrial fibrillation
This study is testing how stopping blood-thinning medication for a short time affects Chinese patients with atrial fibrillation to see if it's safe for them during medical procedures.
-
Preventing blood clots in cancer patients with central venous catheters
This study is testing if a daily dose of a blood thinner called rivaroxaban can help prevent blood clots in cancer patients who have just had a central venous catheter placed.
-
Using rosuvastatin to reduce blood clots in patients with venous thromboembolism
This study is testing if adding rosuvastatin, a cholesterol-lowering drug, can help prevent blood clots from coming back in patients who have recently had a major blood clot event.
-
Comparing daily doses of aspirin to prevent blood clots after joint surgery
This study tests if taking a low dose of aspirin once a day is just as good as taking it twice a day to prevent blood clots in people having hip or knee surgery.
-
Comparing clinical surveillance to anticoagulation for low-risk patients with isolated pulmonary embolism
This study is testing whether low-risk patients with isolated pulmonary embolism can safely be monitored without blood thinners instead of taking them.
-
Using Sulodexide to prevent blood clots in elderly patients
This study is testing if a medication called Sulodexide can help prevent blood clots in elderly patients who have already had one, while being safer than current treatments.
-
CHIPs-VTE program to prevent hospital-acquired blood clots in hospitalized patients
This project tests whether a hospital-wide package of risk checks, computer alerts, staff education, and audits can increase appropriate clot-prevention for hospitalized patients in China.
-
Identifying biomarkers for detecting hidden cancer in patients with blood clots
This study is trying to find new markers in the blood that can help spot hidden cancer in patients who have blood clots.
-
Computerized alerts to prevent blood clots in hospitalized patients
This study is testing if using computer alerts can help doctors give blood clot prevention medication to hospitalized patients who are at risk.
-
Validation of Caprini Score for Patients Undergoing Varicose Vein Surgery
This study is testing if the Caprini score can help identify adults having varicose vein surgery who are at higher risk for blood clots after their procedure.
-
Registry for patients with venous blood clots
This study is creating a database of patients with blood clots to help doctors better understand how to treat them and identify those at higher risk for complications.
-
Survey on patients using anticoagulant medications
This study is looking at how well different blood-thinning medications work and their safety for adults who are starting or changing their anticoagulant treatment.
-
Registry for patients undergoing IVC filter placement or retrieval
This study is collecting information from patients getting an IVC filter placed or removed to see how different removal methods work over time.
NIH-funded research (23)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Statins to Prevent Cancer-Associated Blood Clots in Cancer Patients
A large study will test whether taking rosuvastatin every day for a year can lower the chance of dangerous blood clots in people with cancer, without raising the risk of bleeding.
-
Optimal use of blood thinners for venous clots in people with cirrhosis
This grant hopes to figure out the safest and most effective way to use oral anticoagulants for adults with cirrhosis who develop venous clots.
-
PET/CT imaging to detect chemotherapy-related vascular harm in young cancer patients
A non-invasive PET/CT scan method using standard care imaging is being tested to identify which pediatric and young adult cancer patients are at higher risk of blood clots from chemotherapy.
-
Statins to Prevent Cancer-Associated Blood Clots in Cancer Patients
A large clinical trial will test whether taking rosuvastatin daily for a year helps prevent dangerous blood clots in people with newly diagnosed or relapsed cancer who aren’t already getting anticoagulants.
-
BCOR's role in blood clot risk and liver genetics
A Johns Hopkins-led study is exploring how a human gene, BCOR, may control liver-produced clotting factors to influence venous blood clots.
-
Personalized risk-prediction for hospital-acquired blood clots in adults
A real-time risk model helps doctors identify adults in the hospital who are at higher risk of developing blood clots so they can prevent them safely.
-
Genomic and Proteomic Markers for Recurrent Venous Thromboembolism
Researchers are studying genetic and protein clues to predict who will have another blood clot after an initial VTE event, so doctors can tailor safer, more effective care.
-
Venous clot complications after a first VTE in adults
This study follows adults after a first venous thromboembolism to understand chronic symptoms and health outcomes over the first year.
-
STOP-SCD-VTE: How and when blood thinners are used for adults with sickle cell disease and blood clots
A real-world study of how doctors use long-term blood thinners in adults with sickle cell disease who have had a venous clot, and whether different medicines or patterns affect outcomes.
-
How the BCOR gene may affect risk of dangerous blood clots
Researchers are looking at how the BCOR gene controls a liver protein called Factor VII that can influence the risk of venous blood clots for people prone to VTE.
-
Better ways to predict and prevent blood clots in the hospital
This work creates and tests a new way to help doctors quickly identify hospitalized patients at risk for dangerous blood clots, aiming to prevent them before they happen.
-
Using PET/CT scans to spot vein inflammation and clot risk in children and young adults with cancer
This project uses PET/CT scans with a glucose tracer to look for vein inflammation that may signal higher risk of dangerous blood clots in children, adolescents, and young adults receiving chemotherapy.
-
Understanding long-term effects of blood clots
This study is looking at how people who have had a blood clot, like deep vein thrombosis or pulmonary embolism, might feel in the year after their treatment, especially those using newer blood thinners, to better understand their symptoms and help improve their recovery and care.
-
Preventing blood clots in cancer patients receiving outpatient care
This study is looking at ways to help doctors better prevent blood clots in cancer patients who are not in the hospital, so they can stay safer and healthier during their treatment.
-
Understanding risks and outcomes of blood clots in young patients
This study is looking at blood clots in young people under 21 to find better ways to predict how they will do and improve their treatment, all while helping new researchers learn more about this important health issue.
-
Investigating delays in diagnosing venous thromboembolism in different healthcare settings
This study is looking into why some people with blood clots, like pulmonary embolism and deep vein thrombosis, don’t get diagnosed quickly, and it aims to find ways to improve care for everyone, whether they live in cities or rural areas.
-
Understanding how BCOR affects blood clotting and venous thromboembolism
This study is looking at how certain genes, especially one called BCOR, might affect the chances of developing blood clots, which can be a serious health issue, and it hopes to find new ways to help prevent or treat this condition.
-
Understanding blood clot risks in children with sickle cell disease
This study is looking at what might cause blood clots in children with sickle cell disease, so we can find better ways to prevent and treat these clots and help keep kids healthier.
-
Investigating anticoagulant use for preventing blood clots in patients with inflammatory bowel disease
This study is looking at how well blood-thinning medications can help prevent blood clots in people with inflammatory bowel disease, both when they're in the hospital and at home, while also making sure these treatments are safe for those who might be at higher risk.
-
Improving decision support systems for preventing blood clots in hospitalized patients
This study is working on improving tools that help doctors make better decisions about preventing blood clots, so patients can get the best care based on the latest research.
-
Improving prevention of blood clots in hospitalized patients
This study is looking at ways to help hospitalized patients remember to take their blood clot prevention medications by using real-time support, so they can stay involved in their care and lower their chances of getting preventable blood clots.
-
A telemedicine solution using smart socks to prevent blood clots in older cancer patients
This study is testing a fun and interactive sock that helps older cancer patients stay active and prevent blood clots by turning their foot and ankle exercises into a game, making it easier for them to keep moving and stay healthy.
-
Investigating the role of platelets in blood clot risks for cancer patients
This study is looking at how certain blood cells called platelets might affect the risk of blood clots in cancer patients, and it hopes to find a way to identify those who are more likely to develop these clots so that better prevention methods can be created.
Related topics
Quick answers
How many Venous Thromboembolism clinical trials are recruiting right now?
50, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 41 countries. The most sites are in United States (14 trials), France (12 trials), Canada (9 trials), United Kingdom (7 trials), China (5 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 8, Phase 4: 8, Phase 2: 3, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.